From $5 to $750 million: LIFE Healthcare's bold gamble pays off with massive return on alzheimer's diagnostic sale

Loading player...
Life Healthcare’s bold $5 acquisition of a pioneering Alzheimer’s diagnostic company has led to a stunning $750 million payoff. CEO Peter Wharton-Hood reflects on the strategic risks and rewards, highlighting the company’s focused future in Southern Africa’s healthcare sector, while navigating challenges like National Health Insurance.
15 Jan 6AM English South Africa Investing · Business News

Other recent episodes